Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1461628

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1461628

Global 2DPA-1 Market Size, Share, Growth Analysis, By Application(Pharmaceuticals, Agrochemicals), By End Use(Healthcare, Textile & Dye) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global 2DPA-1 Market size was valued at USD 617.61 billion in 2022 and is poised to grow from USD 641.08 billion in 2023 to USD 863.95 billion by 2031, growing at a CAGR of 3.80% during the forecast period (2024-2031).

The versatile compound DAPA finds extensive application in pharmaceutical synthesis, dye production, and various industrial processes. The global market for 2DPA-1, an innovative chemical compound also known as 2-diphenylacetyl-1,3-indandione, caters to the diverse industrial needs for this synthetic compound with its unique properties. Serving to meet the rising demand, the global 2DPA-1 market focuses on supplying this compound for a broad spectrum of applications, primarily as a chemical intermediate in pharmaceutical, agrochemical, and specialty chemical synthesis. Moreover, it plays a vital role in dye, pigment, and personal care product manufacturing, where its anti-aging, anti-inflammatory, and antioxidant features are highly valued. The expanding global 2DPA-1 market offers lucrative opportunities for industry players to meet the increasing demand for innovative solutions across multiple sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 2DPA-1 Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 2DPA-1 Market Segmental Analysis

Global 2DPA-1 Market is segmented on the basis of application, end user and region. By application, the market is segmented into pharmaceuticals, agrochemicals, cosmetics, and others. By end user, the market is segmented into healthcare, textile & dye, others. By region, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 2DPA-1 Market

The pharmaceutical sector tirelessly seeks fresh and inventive drug prospects to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1, encompassing its anti-inflammatory, anti-cancer, and antiviral effects, propel its integration into drug exploration and advancement efforts, consequently fostering a substantial Compound Annual Growth Rate (CAGR) for the worldwide 2DPA-1 market throughout the projected timeframe.

Restraints in the Global 2DPA-1 Market

The arrival of new players in both regional and global markets has the potential to intensify competition, posing a significant threat to established entities. Enhanced product portfolios introduced by competitors can escalate the stakes for existing players, further heightening the competitive landscape.

Market Trends of the Global 2DPA-1 Market

The complexity and expense involved in producing 2DPA-1 could hinder its broad acceptance across industries, potentially restricting its market expansion. Elevated production costs might constrain the availability and affordability of 2DPA-1, thereby impeding its market growth and resulting in a comparatively lower Compound Annual Growth Rate (CAGR) for the global 2DPA-1 market in the projected timeframe.

Product Code: SQMIG15E2176

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global 2DPA-1 Market by Application

  • Market Overview
  • Pharmaceuticals
  • Agrochemicals
  • Cosmetics
  • Others

Global 2DPA-1 Market by End Use

  • Market Overview
  • Healthcare
  • Textile & Dye
  • Others

Global 2DPA-1 Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Siemens AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi, Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toshiba Medical Systems Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carestream Health, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esaote SpA (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samsung Medison Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agfa-Gevaert NV (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CurveBeam LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Planmed Oy (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Epiroc AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!